Harvard Bioscience (HBIO) Free Cash Flow Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) Free Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 44.68% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 271.70% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -45.89% |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -6.70% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -20.71% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -241.25% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 432.60% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 339.10% |
| 10 | Harvard Bioscience | 26.75 Mn | 19.65 Mn | 12.24 Mn | -144.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -144.00% |
| Dec 31, 2025 | -138.27% |
| Sep 30, 2025 | 150.93% |
| Jun 30, 2025 | 260.22% |
| Mar 31, 2025 | 226.25% |
| Dec 31, 2024 | -59.00% |
| Sep 30, 2024 | -141.55% |
| Jun 30, 2024 | -154.83% |
| Mar 31, 2024 | -52.27% |
| Dec 31, 2023 | 42.10% |
| Sep 30, 2023 | 1,901.93% |
| Jun 30, 2023 | 580.22% |
| Mar 31, 2023 | 164.63% |
| Dec 31, 2022 | 1,114.11% |
| Sep 30, 2022 | 118.16% |
| Jun 30, 2022 | -212.46% |
| Mar 31, 2022 | -377.31% |
| Dec 31, 2021 | -109.93% |
| Sep 30, 2021 | -210.36% |
| Jun 30, 2021 | -73.11% |